Skip to main content

Health and Medicine

Predicting hospital readmission is risky business: study

Oct. 18, 2011—Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.

Read more


Supplements don’t help lung injury patients

Oct. 13, 2011—Supplements did not improve outcomes of patients with acute lung injury.

Read more


Diversity key in antibody repertoire

Oct. 7, 2011—Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

Read more


Fungus toxin gets in the way in DNA

Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.

Read more


Heart protein may be target for colon cancer therapies

Oct. 7, 2011—A protein critical in heart development may also play a part in colon cancer progression.

Read more


Parkinson’s deep brain target fired up

Oct. 5, 2011—Neuronal activity in a deep brain region increases as Parkinson’s disease advances, a new study suggests.

Read more


Drug-like molecules aimed at improving treatment of Parkinson’s

Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.

Read more


Folate may lower breast cancer risk for some

Sep. 29, 2011—Low folate levels may increase a premenopausal woman’s risk of developing breast cancer.

Read more


Study puts a new spin on ibuprofen’s actions

Sep. 29, 2011—Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.

Read more


New study confirms safety of eight vaccines

Sep. 28, 2011—A report released by the Institute of Medicine confirms the safety of eight vaccines studied by a committee of experts. Evidence showed no links between immunization and serious conditions that have raised concerns, including Type 1 diabetes and autism.

Read more


Examining the ethics of sharing genetic risk information

Sep. 28, 2011—Should scientists inform participants in genomic studies about their risk for diseases or conditions discovered during the studies, and if so, when and how? A Vanderbilt professor is part of a team working to answer these questions.

Read more


Interactive brain exhibit opens at Vanderbilt Health One Hundred Oaks

Sep. 27, 2011—A state-of-the-art interactive exhibit on the brain and brain research has opened at Vanderbilt Health One Hundred Oaks.

Read more


Upcoming Events

MORE EVENTS »